The discoverer of Rapamycin treated himself with Rapamycin to delay his own death from cancer

In 1999, the U.S. Food and Drug Administration approved rapamycin as a drug for transplant patients. Sehgal died a few years after the FDA approval, too soon to see his brainchild save the lives of thousands of transplant patients and go on to make Wyeth hundreds of millions of dollars. Nextbigfuture has dozens of articles …

Read more